Table 1

Patient demographics and outcomes for infants born less than 29 weeks gestation admitted to neonatal units in England and treated with iNO

2010–20112012–20132014–2015
Neonatal admissions requiring ≥1 day of intensive care (with and without iNO)673065876410
Infants treated with iNO329 (4.9%*)611 (9.3%*)1019 (15.9%*)
Birth weight (g)790 (65 0,950)795 (67 0,985)790 (66 0,985)
Gestational age (weeks)26 (24, 27)26 (24, 27)26 (24, 27)
Male sex180 (55%)364 (60%)553 (54%)
Prolonged rupture of membranes >24 hours†113 (34.4%)190 (31.1%)173 (17.0%)
Surfactant therapy in labour ward or neonatal unit324 (98.5%)589 (96.4%)935 (91.8%)
Initiation of iNO therapy (day)10 (2,33)13 (2,46)18 (3,48)
Duration of iNO therapy (days)3 (2,5)2 (1,4)2 (1,4)
Diagnosis (not mutually exclusive)‡
Respiratory distress§ syndrome255 (77.5%)505 (82.7%)920 (90.3%)
Pulmonary hypoplasia30 (9.1%)40 (6.6%)49 (4.8%)
Pulmonary hypertension100 (30.4%)164 (26.8%)260 (25.5%)
Congenital pneumonia2 (0.6%)2 (0.3%)10 (1.0%)
Congenital diaphragmatic hernia001 (0.1%)
Death among infants who received iNO143 (43.5%)224 (36.7%)242 (23.8%)
  • The denominator for all proportions is the number of babies treated with iNO unless indicated otherwise.

  • *Denominator is all admissions to neonatal unit admissions requiring ≥1 day of intensive care. All values are given as n, % or median (25th,75th centiles), as appropriate.

  • †Prolonged rupture of membranes >24 hours uses a combination of discharge diagnoses and recorded duration of rupture of membranes.

  • ‡Extracted codes available in online supplemental file.

  • §This includes the diagnosis respiratory distress syndrome and signs of respiratory distress of newborn (see online supplemental file 1).

  • iNO, inhaled nitric oxide.